Advances in Controlled Delivery of Therapeutic Biomacromolecules

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 161

Special Issue Editors


E-Mail Website
Guest Editor
CITENI-Centro de Investigacións Navais e Industriais, Universidade da Coruña, Campus Industrial, Ferrol, 15403 A Coruña, Spain
Interests: pharmaceutical technology; biomaterials; hydrogels; pharmacokinetics; drug delivery

E-Mail Website
Guest Editor
MackGraphe, Instituto Presbiteriano Mackenzie, São Paulo 01302-907, Brazil
Interests: biomaterials; biocompatible polymers; nanotechnology; drug delivery

Special Issue Information

Dear Colleagues,

Currently, therapeutic macromolecules are popular for the treatment of several diseases. Enzymes, proteins, peptide-based actives or genetic material are being investigated in terms of action, yet the special characteristics of these type of actives could be an issue for their delivery to the therapeutic target. Over the last few decades, one of the goals of drug delivery science has been to develop systems able to host and maintain the activity of these molecules.

This Special Issue, entitled “Advances in Controlled Delivery of Therapeutic Biomacromolecules”, aims to present the current state of the art of the field. Emphasis is placed on novel platforms and materials for their delivery through any administration route, highlighting the most challenging aspects of modern biopharmaceutical science.

We invite research scientists from the pharmaceutical industry or academia to submit original research articles, review articles with a focus on novel therapeutic biomolecule delivery systems.

Dr. María Isabel Rial-Hermida
Dr. Caroline Santos A. De Lima
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • therapeutic peptides and proteins
  • drug delivery systems
  • pharmacokinetics
  • hydrogels
  • nanotechnology
  • targeting
  • advanced formulations for drug delivery
  • microemulsions
  • growth factors
  • gens
  • pharmaceutical technology
  • biomaterials
  • enzymes
  • mAb

Published Papers

This special issue is now open for submission.
Back to TopTop